GSEA analysis revealed significant enrichment of ANOS1 in multiple oncogenic pathways, particularly extracellular matrix (ECM) receptor interactions, focal adhesion, hematopoietic cell lineage, chemokine signaling pathways, pathways in cancer, and transforming growth factor-β signaling pathway. The gene discussed is ANOS1; the disease is cancer.